Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Deeber who wrote (22)	4/14/1997 2:42:00 PM
From: Deeber	of 2515

NEWS RELEASE: Monday April 14 11:09 AM EDT Imclone Systems Inc cancer drug results "promising" NEW YORK, April 14 (Reuter) - ImClone Systems Inc said Monday that results of a preclinical study of its lead cancer therapeutic, C225, an epidermal growth factor receptor antagonist, were "promising." ImClone said that treatment with C225 in human bladder carcinoma cells growing orthotopically in mice resulted in a significant inhibition of tumor growth compared with controls. The company said that the orthotopic approach utilized in this study is a cancer model that implants human tumor cells into the tissue of origin in the mouse, thus making the model a more realistic indicator of tumor progression. .....not sure why stock is down though, was up big today on the news.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next